Setanaxib TRANSFORM study now enrolling

The purpose of this clinical research study is to evaluate the effects of an investigational product (setanaxib) as a potential additional treatment for PBC. The study is now enrolling in Ontario:  Toronto, London, North Bay and in Calgary, Alberta. To learn more about the TRANSFORM study and whether or not you might be able to participate, click here.